The return of the biotech scorecard
Article Abstract:
Periodical check on investments is essential by watching the stock picks and comparing them with passive investments that imitate the well-known market averages. It indicates that choosing individual stocks would be worth the effort versus passive index investing.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
PEGing biotech growth
Article Abstract:
The growth investments seen in the biotech companies are discussed. The annual free cash flow (FCF) and the price (P) to earnings (E) ratio predicts the company's growth projections and offer the most potential gain for the work involved in finding.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
How do your stocks really perform?
Article Abstract:
The accurate measures and tools that help gain profit in biotechnology investments are presented. The periodic investment is suggested to be the best way in biotechnology investments rather than a lump sum investment.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The number on biotech indexes. Putting biotech risk in its place. Going short on biotech
- Abstracts: Politics torpedo biotech as EU priority. Taiwan: biotech vision. Germany biotech gets second chance
- Abstracts: Three US states launch biotech seed funds. Global biotech expansion taking cues from Bayh-Dole. Unlocking the money-making potential of RNAi
- Abstracts: Beware of third parties bearing lawsuits. Quadropoly. Stoy story
- Abstracts: Meet the new public company. Spain's banks bet big on Latin America. Accounting proposal hits 'CoCo' bonds